Literature DB >> 2840361

DNA aneuploidy and cell proliferation in familial adenomatous polyposis.

P Quirke1, M F Dixon, D W Day, J B Fozard, I C Talbot, C C Bird.   

Abstract

Two hundred and thirteen samples from 20 patients with familial adenomatous polyposis (FAP) were investigated by flow cytometry and the results compared with 100 sporadic adenomas. Eleven of the 20 (55%) yielded one or more DNA aneuploid samples with an overall incidence within FAP adenomas of 12%. Despite a similar level of DNA aneuploidy in sporadic adenomas, it was commonly detected at a smaller polyp size. The degree of cell proliferation was found to be similar in the two groups (median %S+G2 15.8% v 16.4%) but larger FAP adenomas demonstrated a higher level of cell proliferation than smaller adenomas. DNA aneuploidy had no value as a predictor of a synchronous carcinoma and appeared to be an early change in the development of carcinoma in these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840361      PMCID: PMC1433657          DOI: 10.1136/gut.29.5.603

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Premalignancy of the mucosal polyp in the large intestine: I. Histologic gradation of the polyp on the basis of epithelial pseudostratification and glandular branching.

Authors:  S Kozuka
Journal:  Dis Colon Rectum       Date:  1975-09       Impact factor: 4.585

2.  Detection of in vitro tetraploidy in heritable colon cancer syndromes. Confirmation by three different assays.

Authors:  B S Danes; E E Deschner
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

3.  Flow cytometric detection of aneuploidy in colorectal adenomas.

Authors:  H F van den Ingh; G Griffioen; C J Cornelisse
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

4.  DNA aneuploidy in ulcerative colitis.

Authors:  J B Fozard; P Quirke; M F Dixon; G R Giles; C C Bird
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

5.  Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.

Authors:  P Quirke; M F Dixon; A D Clayden; P Durdey; J E Dyson; N S Williams; C C Bird
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

6.  Familial polyposis coli: growth characteristics of karyotypically variable cultured fibroblasts, response to epidermal growth factor and the tumour promoter 12-0-tetradecanoyl phorbol-13-acetate.

Authors:  S H Rider; H A Mazzullo; M B Davis; J D Delhanty
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

7.  Histopathological analysis of benign polyps in patients with carcinoma of the colon and rectum.

Authors:  G Ekelund; C Lindström
Journal:  Gut       Date:  1974-08       Impact factor: 23.059

8.  DNA content and the adenoma-carcinoma sequence in the colorectum.

Authors:  H S Goh; J R Jass
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

9.  Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study.

Authors:  L J Brown; N C Smeeton; M F Dixon
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

10.  DNA aneuploidy in colorectal adenomas.

Authors:  P Quirke; J B Fozard; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

View more
  5 in total

Review 1.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

2.  Comparative DNA analyses in longstanding ulcerative colitis with aneuploidy.

Authors:  R Löfberg; T Caspersson; B Tribukait; A Ost
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

3.  Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.

Authors:  Yang Wang; Robert J Coffey; Neil Osheroff; Kristi L Neufeld
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

4.  Ornithine decarboxylase as a marker for premalignancy in the stomach.

Authors:  S E Patchett; E M Alstead; L Butruk; K Przytulski; M J Farthing
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

5.  Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

Authors:  C F Sier; H J Vloedgraven; G Griffioen; S Ganesh; F M Nagengast; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.